Inventor

ZITVOGEL LAURENCE

FR23 patents

⚠️ This page may combine multiple inventors who share the name “ZITVOGEL LAURENCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZITVOGEL LAURENCE

ROUSSY INST GUSTAVE

Methods for activating natural killer (NK) cells and means for carrying out said methods

Method of treatment for immunogenic treatment resistant cancer

Treatment of cancer using TLR3 agonists

Combination of oncolytic virus with immune checkpoint modulators

Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment

Microbiota composition, as a marker of responsiveness to anti-PD1/PD-L1/PD-L2 antibodies and use of microbial modulators for improving the efficacy of an anti-PD1/PD-L1/PD-L2 ab-based

Immunogenic sequences from a phage tail length tape measure protein, bacteria expressing the same and their use in treating a cancer

Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment

Microbiota composition, as a marker of responsiveness to anti-PD1/PD-L1/PD-L2 antibodies and use of microbial modulators for improving the efficacy of an anti-PD1/PD-L1/PD-L2 AB-based treatment

Bacterial and cell compositions for the treatment of colorectal cancer and methods for assessing a prognosis for patients having the same

Methods of treating gastrointestinal sarcoma patients depending on their sB7H6 serum level

Methods for predicting the sensitivity of a subject to immunotherapy

ZITVOGEL LAURENCE

Natural killer p30 (NKp30) dysfunction and the biological applications thereof

Compounds and uses thereof to induce an immunogenic cancer cell death in a subject

LYTIX BIOPHARMA AS

Immune checkpoint inhibitor combinations

Immune checkpoint inhibitor combinations

KROEMER GUIDO

Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereof

Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment

INST NAT SANTE RECH MED

Sensitization process for antigen-presenting cells and means for implementing the process

CENTRE NAT RECH SCIENT

Sensitization process for antigen-presenting cells and means for implementing the process

ANDRE FABRICE

Treatment of cancer using TLR3 agonists

APETOH LIONEL

Toll like receptor 4 dysfunction and the biological applications thereof

UNIV TEXAS

Methods and compositions for treating cancer